Study of CTX-M Type of Extended Spectrum β-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India

Indian Journal of Microbiology

Volumn 52, Issue 1, 2012, Pages 35-40

  Parveen, R Mohamudha ^a   Manivannan, Subha ^a   Harish, B N ^a   Parija, S C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antibiotic resistance; CTX M types; Extended spectrum lactamase; Nosocomial isolates; South India

Indexed keywords

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 84858005963     PISSN: 00468991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12088-011-0140-3     Document Type: Article

References (25)

1. Bush K (2001) New β-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32: 1085-1089.
2. Jacoby GA, Munoz-Price LS (2005) The new β-lactamases. N Engl J Med 352: 380-391.
3. Bonnet R (2004) Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48: 1-14.
4. Radice M, Power P, DiConza J, Gutkind G (2002) Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 46: 602-604.
5. Mulvey MR, Bryce E, Boyd D, Agostini OM, Christianson S, Simor AE (2004) Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother 48: 1204-1214.
6. Wang H, Kelkar S, Wu W, Chen M, Quinn JI (2003) Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother 47: 790-793.
7. Yamasaki Y, Komatsu M, Yamashita T (2003) Production of CTX-M-3 extended-spectrum beta-lactamases and IMP-1 metallo-beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000 in the Kinki region of Japan. Antimicrob Agents Chemother 51: 631-638.
8. Cao V, Lambert T, Nhu DQ (2002) Distribution of extended spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother 46: 3739-3754.
9. Bradford PA, Yang Y, Sahm D, Grope I, Gardovska D, Storch G (1998) CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhyimurium in Latvia. Antimicrob Agents Chemother 42: 1980-1984.
10. Centers for Disease Control National Nosocomial Study Site Definition Manual (1999) Center for Disease Control, Atlanta.
11. Crichton PB Enterobacteriaceae. Escherichia, Klebsiella, Proteus and other genera. In: Collee JG, Fraser AG, Marmion BP, Simmons A (eds) Mackie and McCartney practical medical microbiology. 14th edn, Chap 20. Churchill Livingstone.
12. Clinical and Laboratory Standards (2007) Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement. Clinical and Laboratory Standards Institute, Wayne. M100-S17.
13. Pitout JD, Hamilton N, Church DL, Nordmann P, Poirel L (2007) Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type b-lactamases in Enterobacteriaceae. Clin Microbiol Infect 13: 291-297.
14. Pitout JD, Hossain A, Hanson ND (2004) Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 42: 5715-5721.
15. Alobwede I, M'Zali FH, Livermore DM, Heritage J, Todd N, Hawkey PM (2003) CTX-M extended-spectrum β-lactamase arrives in the UK. J Antimicrob Chemother 51: 470-471.
16. Gheldre YD, Avesani V, Berhin C, Delmee M, Glupezynski Y (2003) Evaluation of oxoid combination discs for detection of extended-spectrum-b-lactamases. J Antimicrob Chemother 52: 591-597.
17. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriacae produced extended spectrum β-lactamases (ESBLs) in the community. J Antimicob Chemother 56: 52-59.
18. Yu WL, Pfaller MA, Winokur PL, Jones RN (2002) Cefepime MIC as a predictor of the extended-spectrum beta-lactamase type in Klebsiella pneumoniae, Taiwan. Emerg Infect Dis 8: 522-524.
19. Ensor VM, Shahid M, Evans JT, Hawkey PM (2006) Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58: 1260-1263.
20. Bonnet R, Sampaio JL, Labia R, De Champs C, Sirot D, Chanal C et al (2000) A novel CTX-M beta-lactamase (CTX-M-8) in-resistant Enterobacteriaceae isolated in Brazil. Antimicrob Agents Chemother 44: 1936-1942.
21. Chanawong A, M'Zali FH, Heritage J, Xiong JH, Hawkey PM (2002) Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother 46: 630-637.
22. Jemima SA, Verghese S (2008) Molecular characterization of nosocomial CTX-M type β-lactamase producing Enterobacteriaceae from a tertiary care hospital in South India. Indian J Med Microbiol 26: 365-368.
23. Karim A, Poirel L, Nagarajan S (2001) Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 201: 237-241.
24. Walsh TR, Toleman MA, Jones RN (2007) Comment on: occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 59: 799-800.
25. Khurana S, Taneja N, Sharma M (2002) Extended spectrum β-lactamase mediated resistance in urinary tract isolates of family Enterobacteriaceae. Indian J Med Res 116: 145-149.